Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.

Brolund A, Lagerqvist N, Byfors S, Struelens MJ, Monnet DL, Albiger B, Kohlenberg A; European Antimicrobial Resistance Genes Surveillance Network EURGen-Net Capacity Survey Group.

Euro Surveill. 2019 Feb;24(9). doi: 10.2807/1560-7917.ES.2019.24.9.1900123.

2.

Networking of Public Health Microbiology Laboratories Bolsters Europe's Defenses against Infectious Diseases.

Albiger B, Revez J, Leitmeyer KC, Struelens MJ.

Front Public Health. 2018 Feb 26;6:46. doi: 10.3389/fpubh.2018.00046. eCollection 2018.

3.

Survey on the Use of Whole-Genome Sequencing for Infectious Diseases Surveillance: Rapid Expansion of European National Capacities, 2015-2016.

Revez J, Espinosa L, Albiger B, Leitmeyer KC, Struelens MJ; ECDC National Microbiology Focal Points and Experts Group.

Front Public Health. 2017 Dec 18;5:347. doi: 10.3389/fpubh.2017.00347. eCollection 2017.

4.

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.

Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, Cantón R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Monnet DL; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group.

Lancet Infect Dis. 2017 Feb;17(2):153-163. doi: 10.1016/S1473-3099(16)30257-2. Epub 2016 Nov 18.

PMID:
27866944
5.

Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group.

Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30062. Erratum in: Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30089. Euro Surveill. 2016 Sep 22;21(38):.

6.

European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics.

Earnshaw S, Mancarella G, Mendez A, Todorova B, Magiorakos AP, Possenti E, Stryk M, Gilbro S, Goossens H, Albiger B, Monnet DL; European Antibiotic Awareness Day Technical Advisory Committee; European Antibiotic Awareness Day Collaborative Group.

Euro Surveill. 2014 Oct 16;19(41). pii: 20928.

7.

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.

Glasner C, Albiger B, Buist G, Tambić Andrasević A, Canton R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Donker T, Monnet DL, Grundmann H; European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group.

Euro Surveill. 2013 Jul 11;18(28). pii: 20525. Erratum in: Euro Surveill. 2013;18. pii: 20575. Euro Surveill. 2014;19(47): pii=20972.

8.

Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis.

Kalle M, Papareddy P, Kasetty G, Mörgelin M, van der Plas MJ, Rydengård V, Malmsten M, Albiger B, Schmidtchen A.

PLoS One. 2012;7(12):e51313. doi: 10.1371/journal.pone.0051313. Epub 2012 Dec 13.

9.

Structure-activity studies and therapeutic potential of host defense peptides of human thrombin.

Kasetty G, Papareddy P, Kalle M, Rydengård V, Mörgelin M, Albiger B, Malmsten M, Schmidtchen A.

Antimicrob Agents Chemother. 2011 Jun;55(6):2880-90. doi: 10.1128/AAC.01515-10. Epub 2011 Mar 14.

10.

C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules.

Papareddy P, Kalle M, Kasetty G, Mörgelin M, Rydengård V, Albiger B, Lundqvist K, Malmsten M, Schmidtchen A.

J Biol Chem. 2010 Sep 3;285(36):28387-98. doi: 10.1074/jbc.M110.127019. Epub 2010 Jun 30.

11.

Streptococcus pneumoniae induces expression of the antibacterial CXC chemokine MIG/CXCL9 via MyD88-dependent signaling in a murine model of airway infection.

Eliasson M, Mörgelin M, Farber JM, Egesten A, Albiger B.

Microbes Infect. 2010 Jul;12(7):565-73. doi: 10.1016/j.micinf.2010.03.014. Epub 2010 Apr 8.

PMID:
20381636
12.

Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression.

Littmann M, Albiger B, Frentzen A, Normark S, Henriques-Normark B, Plant L.

EMBO Mol Med. 2009 Jul;1(4):211-22. doi: 10.1002/emmm.200900025.

13.

Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion.

Dieudonné-Vatran A, Krentz S, Blom AM, Meri S, Henriques-Normark B, Riesbeck K, Albiger B.

J Immunol. 2009 Jun 15;182(12):7865-77. doi: 10.4049/jimmunol.0802376.

14.

Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.

Blomberg C, Dagerhamn J, Dahlberg S, Browall S, Fernebro J, Albiger B, Morfeldt E, Normark S, Henriques-Normark B.

J Infect Dis. 2009 Apr 1;199(7):1032-42. doi: 10.1086/597205.

PMID:
19203261
15.

Clonal success of piliated penicillin nonsusceptible pneumococci.

Sjöström K, Blomberg C, Fernebro J, Dagerhamn J, Morfeldt E, Barocchi MA, Browall S, Moschioni M, Andersson M, Henriques F, Albiger B, Rappuoli R, Normark S, Henriques-Normark B.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12907-12. Epub 2007 Jul 20.

16.

Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors.

Albiger B, Dahlberg S, Henriques-Normark B, Normark S.

J Intern Med. 2007 Jun;261(6):511-28. Review.

17.

Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps.

Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, Henriques-Normark B.

Cell Microbiol. 2007 May;9(5):1162-71. Epub 2007 Jan 9.

PMID:
17217430
18.

Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection.

Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S, Henriques-Normark B.

Cell Microbiol. 2007 Mar;9(3):633-44. Epub 2006 Sep 27.

PMID:
17004992
19.

An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps.

Beiter K, Wartha F, Albiger B, Normark S, Zychlinsky A, Henriques-Normark B.

Curr Biol. 2006 Feb 21;16(4):401-7.

20.

A pneumococcal pilus influences virulence and host inflammatory responses.

Barocchi MA, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, Dahlberg S, Fernebro J, Moschioni M, Masignani V, Hultenby K, Taddei AR, Beiter K, Wartha F, von Euler A, Covacci A, Holden DW, Normark S, Rappuoli R, Henriques-Normark B.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2857-62. Epub 2006 Feb 15.

21.

Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.

Albiger B, Sandgren A, Katsuragi H, Meyer-Hoffert U, Beiter K, Wartha F, Hornef M, Normark S, Normark BH.

Cell Microbiol. 2005 Nov;7(11):1603-15.

PMID:
16207247
22.

Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.

Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B.

J Infect Dis. 2005 Sep 1;192(5):791-800. Epub 2005 Jul 21.

PMID:
16088828
24.

Neisseria meningitidis undergoes PilC phase variation and PilE sequence variation during invasive disease.

Rytkönen A, Albiger B, Hansson-Palo P, Källström H, Olcén P, Fredlund H, Jonsson AB.

J Infect Dis. 2004 Feb 1;189(3):402-9. Epub 2004 Jan 20.

PMID:
14745697
25.

CD46 in meningococcal disease.

Johansson L, Rytkonen A, Bergman P, Albiger B, Källström H, Hökfelt T, Agerberth B, Cattaneo R, Jonsson AB.

Science. 2003 Jul 18;301(5631):373-5.

26.
27.

Gonococci cause immunosuppression by engaging a coinhibitory receptor on T lymphocytes.

Normark S, Albiger B, Jonsson AB.

Nat Immunol. 2002 Mar;3(3):210-1. No abstract available.

PMID:
11875456
28.

Soluble pilin of Neisseria gonorrhoeae interacts with human target cells and tissue.

Rytkönen A, Johansson L, Asp V, Albiger B, Jonsson AB.

Infect Immun. 2001 Oct;69(10):6419-26.

29.

Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence.

Källström H, Blackmer Gill D, Albiger B, Liszewski MK, Atkinson JP, Jonsson AB.

Cell Microbiol. 2001 Mar;3(3):133-43.

PMID:
11260136
30.

IS1294, a DNA element that transposes by RC transposition.

Tavakoli N, Comanducci A, Dodd HM, Lett MC, Albiger B, Bennett P.

Plasmid. 2000 Jul;44(1):66-84.

PMID:
10873528
31.

pUB2380: characterization of a ColD-like resistance plasmid.

Albiger B, Comanducci A, Dodd HM, Tavakoli N, Lett MC, Bennett P.

Plasmid. 2000 Jul;44(1):54-65.

PMID:
10873527

Supplemental Content

Loading ...
Support Center